Mutations of the catalytic subunit a of PI3K (PIK3CA) in erlotinib-treated non-small cell lung cancer (NSCLC) patients (p) with epidermal growth factor receptor (EGFR) mutations.
E. Carcereny
No relevant relationships to disclose
M. A. Molina
No relevant relationships to disclose
J. J. Sanchez
No relevant relationships to disclose
J. Bertran-Alamillo
No relevant relationships to disclose
C. Mayo
No relevant relationships to disclose
E. Aldeguer
No relevant relationships to disclose
A. Gimenez Capitan
No relevant relationships to disclose
Z. Yeste
No relevant relationships to disclose
C. Costa
No relevant relationships to disclose
S. Benlloch
No relevant relationships to disclose
A. Martinez
No relevant relationships to disclose
C. Buges
No relevant relationships to disclose
J. Bosch
No relevant relationships to disclose
D. Isla
No relevant relationships to disclose
M. Domine
No relevant relationships to disclose
M. Provencio
No relevant relationships to disclose
J. M. Sanchez
No relevant relationships to disclose
C. Camps
No relevant relationships to disclose
M. Taron
No relevant relationships to disclose
R. Rosell
No relevant relationships to disclose